Collegium Pharmaceutical (COLL) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Collegium Pharmaceutical (COLL) over the last 7 years, with Q3 2025 value amounting to $0.84.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted) rose 21111.11% to $0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.61, marking a year-over-year decrease of 3060.34%. This contributed to the annual value of $1.86 for FY2024, which is 4418.6% up from last year.
- As of Q3 2025, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) stood at $0.84, which was up 21111.11% from $0.34 recorded in Q2 2025.
- Over the past 5 years, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) peaked at $1.79 during Q2 2021, and registered a low of -$0.73 during Q4 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.34 (2023), whereas its average is $0.28.
- In the last 5 years, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) plummeted by 46500.0% in 2021 and then soared by 520000.0% in 2023.
- Collegium Pharmaceutical's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.73 in 2021, then skyrocketed by 71.23% to -$0.21 in 2022, then surged by 490.48% to $0.82 in 2023, then plummeted by 56.1% to $0.36 in 2024, then soared by 133.33% to $0.84 in 2025.
- Its last three reported values are $0.84 in Q3 2025, $0.34 for Q2 2025, and $0.07 during Q1 2025.